Background The presence of myocardial fibrosis is associated with worse clinical outcomes
in hypertrophic cardiomyopathy (HCM). Cardiovascular magnetic resonance (CMR) with late …

Objectives This study examined fibrosis progression in hypertrophic cardiomyopathy (HCM)
patients, as well as its relationship to patient characteristics, clinical outcomes, and its effect …

Aims Myocardial fibrosis as detected by late gadolinium enhancement (LGE) on cardiac
magnetic resonance (CMR) is a powerful prognostic marker in hypertrophic cardiomyopathy …

Background In hypertrophic cardiomyopathy (HCM), autopsy studies revealed both
increased focal and diffuse deposition of collagen fibers. Late gadolinium enhancement …

Objective We hypothesised that, in hypertrophic cardiomyopathy (HCM), late gadolinium
enhancement (LGE) on cardiac magnetic resonance (CMR) is progressive and can be …

Aims In hypertrophic cardiomyopathy (HCM), attempts to associate genotype with phenotype
have largely been unsuccessful. More recently, cardiac magnetic resonance (CMR) imaging …

In hypertrophic cardiomyopathy (HCM), the clinical significance attributable to the broad
range of left ventricular (LV) systolic function, assessed as the ejection fraction (EF), is …

Objectives: This study sought to assess the rate of progression of fibrosis by 2 consecutive
cardiac magnetic resonance (CMR) examinations and its relation with clinical variables …

Objectives: In this study we sought to explore the relationship between cardiac magnetic
resonance (CMR) with late gadolinium enhancement (LGE) and histopathological …

Objectives: We investigated the significance of fibrosis detected by late gadolinium
enhancement cardiovascular magnetic resonance for the prediction of major clinical events …